Universal Access and Affordable Medicines

Joint Statement on the Special session of the WHO Regional Committee for Europe

by European Public Health Alliance | May 10, 2022 | Health Inequalities, Mental Health, Ukraine, Universal Access and Affordable Medicines

The European Public Health Alliance (EPHA), the European Public Health Association (EUPHA), the Association of Schools of Public Health in the European Region (ASPHER), and the World Federation of Public Health Associations (WFPHA), the leading European and...

EPHA’s response to WHO public hearings regarding a new international instrument on pandemic preparedness and response

by European Public Health Alliance | Apr 22, 2022 | Antimicrobial Resistance | Latest Developments, Non Communicable Diseases (NCDs), Universal Access and Affordable Medicines

WHO has been seeking public input to support the work of the Intergovernmental Negotiating Body (INB) in drafting and negotiating an international instrument to strengthen pandemic prevention, preparedness and response. In their first round of public hearings on 12-13...

European Parliament’s special committee on COVID-19 is an opportunity to drive health equity forward

The European Parliament is undertaking an extremely important task of examining how the European Union has dealt with the response to the ongoing COVID-19 pandemic. We know that its impact on almost every aspect of our lives and livelihoods has been and often...

Market mechanisms cannot be the solution to global health threats

by European Public Health Alliance | Feb 25, 2022 | COVID-19, The View from EPHA, Universal Access and Affordable Medicines | Analysis & Opinion

Guest article by Tamsin Rose, Senior Fellow for Health at Friends of Europe and former Secretary-General at EPHA COVID-19 was unprecedented but not unpredicted. In 2018, the WHO designated ‘Disease X‘ as representing the knowledge that a serious international epidemic...

The Slovenian Presidency of the EU and access to medicines: What’s next?

by Yannis Natsis | Dec 28, 2021 | Universal Access and Affordable Medicines | Analysis & Opinion

The December 2021 Council Conclusions negotiated under the Slovenian Presidency of the EU and signed off by all 27 EU Health Ministers offer a helpful snapshot of where the pharmaceuticals debate stands today, nearly two years into the COVID-19 pandemic and one year...

Synopsis Report: EPHA’s access to medicines (A2M) dialogues series 2021

by European Public Health Alliance | Dec 21, 2021 | #A2Medicines

EPHA’s access to medicines, A2MDialogues series started in the second half of 2020 with five episodes of an-hour long, live, online conversations with key decision-makers shaping medicines’ policies in Europe. The series continued in 2021 with four additional episodes...